Brain receptors for antipsychotic drugs and dopamine: direct binding assays
about
Selective noradrenaline reuptake inhibitors for schizophreniaDopamine supersensitivity correlates with D2High states, implying many paths to psychosisOccupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomographySchizophrenia: more dopamine, more D2 receptorsIncreased baseline occupancy of D2 receptors by dopamine in schizophreniaMonoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesHistory of the discovery of the antipsychotic dopamine D2 receptor: a basis for the dopamine hypothesis of schizophreniaPharmacology and biochemistry of haloperidolBinding of [3H]haloperidol to dopamine D2 receptors in the rat striatumAll Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High ReceptorsAnimal Models of Psychosis: Current State and Future Directions.How antipsychotics work-from receptors to reality.Hippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia.Stem cell-derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent modelA functional genomic study of the effects of antipsychotic agent chlorpromazine in PC12 cells.Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazineDopamine and psychosis: theory, pathomechanisms and intermediate phenotypesSpecific glial functions contribute to schizophrenia susceptibility.Estrogen receptor activation and tardive dyskinesia.Multiple receptors for brain dopamineMonoaminergic synapses and schizophrenia: 45 years of neuroleptics.A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia.Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.Is schizophrenia a dopamine supersensitivity psychotic reaction?The "delayed onset" of antipsychotic action--an idea whose time has come and gone.From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.Fifty years chlorpromazine: a historical perspective.Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug.New detection of brain dopamine receptors with (3H)dihydroergocryptine.Dopaminergic stimulation of cyclic AMP accumulation and parathyroid hormone release from dispersed bovine parathyroid cells.Mind molecules.Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia.The binding of haloperidol to human blood platelets and interactions with 5-hydroxytryptamine and dopamine.Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia.A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.Interactions of dopamine and the release of [3H]-taurine and [3H]-glycine from the isolated retina of the rat.Androgen-induced sexual dimorphism in high affinity dopamine binding in the brain transcends the hypothalamic-limbic region.Evidence for an inhibitory presynaptic component of neuroleptic drug action
P2860
Q24197825-DF94E7AD-4191-4413-9CC3-83BB6F05D293Q24556648-9B320BD5-CB1D-4293-BDCB-4C653E836AABQ24630426-D280BCF2-2F9C-421D-9DB7-8D617D489C35Q24630726-712CBC30-0FA5-4ECD-B027-BB62935F29EDQ24676113-2E938259-FA5B-46BD-B649-90382BB74950Q28066691-48C27E41-46EB-4D61-AB0C-2A0266E9C07CQ28283494-51B167BE-41CE-47E9-8305-23DCA7415D28Q28316539-A537911C-971D-4012-B58A-B4595828EE13Q28327835-E36E85DB-390D-41A3-BD47-2A81D96AAE04Q29395121-D9A5297C-2C9C-423B-97BA-66D9FDC66105Q30410153-77D9DFAA-287F-46FF-9170-5B402FBED31FQ30457477-5F5B4EEF-E693-4D7B-AE0E-01FC056D6EE9Q30540732-88737B32-0459-416F-87DF-1CBF1B31DEAEQ30837351-D39CC0CD-2BB8-4FFF-8AB6-11B3048CC3E9Q30971772-4D4FE730-3BF5-496B-B64B-850E9C11CF03Q33186856-A631B703-65B5-43D4-B9E4-5601828E7659Q33729433-646E09BE-E2BB-49DA-95B2-0BB6F6F9D5ADQ33762530-08AC1C8C-6D18-42A1-A757-B5CF78987E11Q33898374-5DBC33B9-CF14-4E3E-B074-47791D23FC52Q33965842-45095E38-5D72-484F-99E6-9D8DFE50B5CEQ34013426-7C9A5946-5BBF-4AC1-B7BA-262AF3392B3BQ34103482-B6F95BD4-DE56-408B-B956-9197DE8A5E29Q34192438-BE9F405C-9EA4-4C04-91ED-39A48A4DC648Q34377871-6DACC043-24FD-4A7E-B830-C98D63142380Q34480502-C5A795A8-8B2F-4AA2-8525-B8FDD41DDCC8Q34632695-3FBD0D7A-CE62-44C8-B442-0EB538451C22Q34965972-6A868D78-C557-4ABF-ACF7-3F01FE00BB42Q35040472-8BEDCFE4-BB3A-4E68-9F74-0C3CB64E272DQ35049300-15FC2A2D-E672-4E40-AC2B-624321642B2FQ35055797-7C07E25F-6623-43E5-85C6-100095C78344Q35065098-E9486C48-3C95-43B5-A521-17EFC024EEA1Q35175354-6E4F9987-1130-44EC-9C4E-7AE0DF9F4D76Q35177457-C7938EE6-4AAC-4C5E-B668-91050F75EED3Q35197029-076D145E-1B01-4224-B270-B3BB7009C5B5Q35229075-96D7B049-3F07-4EDF-A547-FCB35F42FCCEQ35355783-B68BF0B6-B611-40E0-9E3B-CB96E2F0CF9AQ35847706-561E25F6-3B17-4FE5-A0F2-F0663481D347Q36097518-9CE1885D-413C-4EF5-9461-A16CDD39FF13Q36127819-13E6FC38-371B-4BB4-9251-56F8C6167048Q36128065-3D531FF0-AB3D-45A3-8ACA-B460C5143060
P2860
Brain receptors for antipsychotic drugs and dopamine: direct binding assays
description
1975 nî lūn-bûn
@nan
1975 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
name
Brain receptors for antipsychotic drugs and dopamine: direct binding assays
@ast
Brain receptors for antipsychotic drugs and dopamine: direct binding assays
@en
Brain receptors for antipsychotic drugs and dopamine: direct binding assays
@nl
type
label
Brain receptors for antipsychotic drugs and dopamine: direct binding assays
@ast
Brain receptors for antipsychotic drugs and dopamine: direct binding assays
@en
Brain receptors for antipsychotic drugs and dopamine: direct binding assays
@nl
prefLabel
Brain receptors for antipsychotic drugs and dopamine: direct binding assays
@ast
Brain receptors for antipsychotic drugs and dopamine: direct binding assays
@en
Brain receptors for antipsychotic drugs and dopamine: direct binding assays
@nl
P2093
P2860
P3181
P356
P1476
Brain receptors for antipsychotic drugs and dopamine: direct binding assays
@en
P2093
P2860
P304
P3181
P356
10.1073/PNAS.72.11.4376
P407
P577
1975-11-01T00:00:00Z